FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891301257> ?p ?o ?g. }

• W2891301257 endingPage "895" @default.
• W2891301257 startingPage "887" @default.
• W2891301257 abstract "Bipolar disorder prevalence rates vary in the older adult population (defined as age ≥ 65 years), ranging from 1% in community dwellers to as high as 8-10% in hospital inpatients. Although older agents, including lithium and valproic acid, offer significant antimanic efficacy, as supported by a recent randomized controlled trial (RCT), there is growing interest in using atypical antipsychotics to treat bipolar disorder in older adults. Newer atypical antipsychotics are of interest based on their tolerability and efficacy in the general adult bipolar population. The aim of this review was to systematically examine efficacy and tolerability of newer atypical antipsychotics for older adult bipolar disorder (OABD). We conducted a systematic search utilizing the MEDLINE, EMBASE, PsycINFO and Cochrane Library electronic databases, with the aim of identifying all RCTs comparing newer atypical antipsychotics approved by the US FDA since 2002 (including brexpiprazole, cariprazine, lurasidone, iloperidone, asenapine, paliperidone, and aripiprazole) with placebo or another comparator, in the treatment of any phase of bipolar disorder (including mania, depression or mixed episodes while used as an acute or maintenance treatment) in older adults (> 65 years). We found no RCT data on any of the examined agents. Hence, we changed our search criteria to include studies with a lower age cut-off (≥ 55 years), as well as the inclusion of post hoc studies. Two post hoc studies on lurasidone suggest its reasonable safety and efficacy profile in the acute and maintenance treatment of OABD; however, there are no pharmacoeconomic data on the use of lurasidone in the treatment of OABD. Research data from open-label studies on oral asenapine and aripiprazole as add-on therapy suggest that these two agents are adequately tolerated and improved symptoms of depression and mania in OABD; hence, there is an urgent need to conduct RCTs on these two agents. Lastly, we found no studies for the treatment of OABD with brexpiprazole, cariprazine, iloperidone, or paliperidone." @default.
• W2891301257 created "2018-09-27" @default.
• W2891301257 creator A5058632199 @default.
• W2891301257 creator A5066249013 @default.
• W2891301257 creator A5069084499 @default.
• W2891301257 creator A5069770468 @default.
• W2891301257 creator A5072893953 @default.
• W2891301257 creator A5077689458 @default.
• W2891301257 date "2018-09-06" @default.
• W2891301257 modified "2023-10-16" @default.
• W2891301257 title "A Review of the Pharmacological and Clinical Profile of Newer Atypical Antipsychotics as Treatments for Bipolar Disorder: Considerations for Use in Older Patients" @default.
• W2891301257 cites W1560858304 @default.
• W2891301257 cites W1572608034 @default.
• W2891301257 cites W1780931260 @default.
• W2891301257 cites W1935737369 @default.
• W2891301257 cites W1950164447 @default.
• W2891301257 cites W1973117280 @default.
• W2891301257 cites W1975129134 @default.
• W2891301257 cites W1976678957 @default.
• W2891301257 cites W1996752075 @default.
• W2891301257 cites W2003490971 @default.
• W2891301257 cites W2005221862 @default.
• W2891301257 cites W2006478810 @default.
• W2891301257 cites W2009832071 @default.
• W2891301257 cites W2012183345 @default.
• W2891301257 cites W2022154008 @default.
• W2891301257 cites W2024410002 @default.
• W2891301257 cites W2026694656 @default.
• W2891301257 cites W2027243048 @default.
• W2891301257 cites W2028883633 @default.
• W2891301257 cites W2032752614 @default.
• W2891301257 cites W2033470111 @default.
• W2891301257 cites W2039889159 @default.
• W2891301257 cites W2042704160 @default.
• W2891301257 cites W2047889627 @default.
• W2891301257 cites W2048366685 @default.
• W2891301257 cites W2048981614 @default.
• W2891301257 cites W2057651748 @default.
• W2891301257 cites W2063147978 @default.
• W2891301257 cites W2067975928 @default.
• W2891301257 cites W2080370941 @default.
• W2891301257 cites W2080897382 @default.
• W2891301257 cites W2083467470 @default.
• W2891301257 cites W2084058139 @default.
• W2891301257 cites W2098378665 @default.
• W2891301257 cites W2102109773 @default.
• W2891301257 cites W2102447460 @default.
• W2891301257 cites W2105006312 @default.
• W2891301257 cites W2108450329 @default.
• W2891301257 cites W2116763520 @default.
• W2891301257 cites W2119695947 @default.
• W2891301257 cites W2127872656 @default.
• W2891301257 cites W2131207615 @default.
• W2891301257 cites W2135338195 @default.
• W2891301257 cites W2137044087 @default.
• W2891301257 cites W2140802262 @default.
• W2891301257 cites W2149485684 @default.
• W2891301257 cites W2154299176 @default.
• W2891301257 cites W2163368530 @default.
• W2891301257 cites W2165202919 @default.
• W2891301257 cites W2167223183 @default.
• W2891301257 cites W2514389710 @default.
• W2891301257 cites W2744819261 @default.
• W2891301257 cites W2764261639 @default.
• W2891301257 cites W2792027821 @default.
• W2891301257 cites W2912445121 @default.
• W2891301257 cites W4238307377 @default.
• W2891301257 cites W4242766537 @default.
• W2891301257 cites W70440412 @default.
• W2891301257 doi "https://doi.org/10.1007/s40266-018-0579-6" @default.
• W2891301257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30187288" @default.
• W2891301257 hasPublicationYear "2018" @default.
• W2891301257 type Work @default.
• W2891301257 sameAs 2891301257 @default.
• W2891301257 citedByCount "18" @default.
• W2891301257 countsByYear W28913012572019 @default.
• W2891301257 countsByYear W28913012572020 @default.
• W2891301257 countsByYear W28913012572021 @default.
• W2891301257 countsByYear W28913012572022 @default.
• W2891301257 countsByYear W28913012572023 @default.
• W2891301257 crossrefType "journal-article" @default.
• W2891301257 hasAuthorship W2891301257A5058632199 @default.
• W2891301257 hasAuthorship W2891301257A5066249013 @default.
• W2891301257 hasAuthorship W2891301257A5069084499 @default.
• W2891301257 hasAuthorship W2891301257A5069770468 @default.
• W2891301257 hasAuthorship W2891301257A5072893953 @default.
• W2891301257 hasAuthorship W2891301257A5077689458 @default.
• W2891301257 hasBestOaLocation W28913012572 @default.
• W2891301257 hasConcept C118552586 @default.
• W2891301257 hasConcept C126322002 @default.
• W2891301257 hasConcept C168563851 @default.
• W2891301257 hasConcept C197934379 @default.
• W2891301257 hasConcept C2776174506 @default.
• W2891301257 hasConcept C2776412080 @default.
• W2891301257 hasConcept C2776701107 @default.
• W2891301257 hasConcept C2776809841 @default.
• W2891301257 hasConcept C2776921671 @default.
• W2891301257 hasConcept C2778375690 @default.

• next